The PTH (1-84)/non-PTH (1-84) ratio is a risk factor for cardiovascular events in hemodialysis patients

被引:8
作者
Zitt, E. [2 ,3 ]
Kirsch, A. H.
Haueis, M.
Strasak, A. [4 ]
Neyer, U. [2 ,3 ]
Mayer, G.
Rosenkranz, A. R. [1 ]
机构
[1] Med Univ Innsbruck, Univ Klin Innere Med 4, Dept Internal Med 4, A-6020 Innsbruck, Austria
[2] Acad Teaching Hosp Feldkirch, Dept Nephrol & Dialysis, Feldkirch, Austria
[3] VIVIT, Feldkirch, Austria
[4] Med Univ Innsbruck, Dept Med Stat, A-6020 Innsbruck, Austria
关键词
PTH; secondary hyperparathyroidism; PTH (1-84)/non-PTH (1-84) ratio; cardiovascular morbidity; cardiovascular mortality; hemodialysis; CHRONIC KIDNEY-DISEASE; STAGE RENAL-DISEASE; PARATHYROID-HORMONE ASSAYS; INCIDENT DIALYSIS PATIENTS; ALL-CAUSE MORTALITY; VASCULAR CALCIFICATION; BONE HISTOMORPHOMETRY; MINERAL METABOLISM; SERUM-CALCIUM; ASSOCIATION;
D O I
10.5414/CNP75309
中图分类号
R5 [内科学]; R69 [泌尿科学(泌尿生殖系疾病)];
学科分类号
1002 ; 100201 ;
摘要
Background: We hypothesized that the PTH (1-84)/non-PTH (1-84) ratio (PTH ratio) might help to assess cardiovascular risk in hemodialysis patients. Methods: In this prospective cohort study 70 prevalent hemodialysis patients were followed up to 4 years. The PTH ratio was determined at base-line. Primary outcomes were cardiovascular events (CV E) and all-cause mortality. Cumulative event-free survival was compared between patients with a ratio < 1 and those with a ratio > 1. The risk-association of the PTH ratio with CVE was examined using an adjusted Multiple Cox Proportional Hazards model. Results: A PTH ratio > 1 was found in 34 patients (49%). During follow-up 26 patients suffered a CVE. Patients with a CVE showed a higher ratio than patients with event-free survival (p = 0.033). In patients with a ratio > 1 a significantly higher number of CVE occurred (53 vs. 22%; p = 0.013), and these patients showed a significantly shorter event-free survival (p = 0.032). In an adjusted Cox-proportional hazards model a higher PTH ratio was found to be independently associated with an elevated risk for CVE (HR = 3.2; 95% Cl 1.06 - 13.63; p = 0.04). Conclusions: A higher PTH (1-84)/non-PTH (1-84) ratio is associated with an increased risk for CVE in hemodialysis patients and might therefore be useful for cardiovascular risk estimation in this population.
引用
收藏
页码:309 / 318
页数:10
相关论文
共 50 条
  • [21] Structure of non-(1-84) PTH fragments secreted by parathyroid glands in primary and secondary hyperparathyroidism
    D'Amour, P
    Brossard, JH
    Rousseau, L
    Nguyen-Yamamoto, L
    Nassif, E
    Lazure, C
    Gauthier, D
    Lavigne, JR
    Zahradnik, RJ
    KIDNEY INTERNATIONAL, 2005, 68 (03) : 998 - 1007
  • [22] Mechanisms of vasodilation to PTH 1-84, PTH 1-34, and PTHrP 1-34 in rat bone resistance arteries
    Benson, T.
    Menezes, T.
    Campbell, J.
    Bice, A.
    Hood, B.
    Prisby, R.
    OSTEOPOROSIS INTERNATIONAL, 2016, 27 (05) : 1817 - 1826
  • [23] Significance of monitoring Bio-Intact PTH (1-84) during parathyroidectomy for secondary hyperparathyroidism
    Ikeda, Yoshifumi
    Kurihara, Hideko
    Morita, Naomi
    Miyabe, Rika
    Takami, Hiroshi
    JOURNAL OF SURGICAL RESEARCH, 2007, 139 (01) : 83 - 87
  • [24] Effects of Parathyroidectomy on Plasma iPTH and (1-84) PTH Levels in Patients with Stage 5 Chronic Kidney Disease
    Chen Huimin
    Cui Ying
    Xing Changying
    Zha Xiaoming
    Zhang Yan
    Wang Qingting
    Ma Haoyang
    Zhang Lina
    Zeng Ming
    Yang Guang
    Lv Xiaolin
    Purrunsing, Yogendranath
    Wang Ningning
    HORMONE AND METABOLIC RESEARCH, 2018, 50 (10) : 761 - 767
  • [25] PTH(1-84) Administration Reverses Abnormal Bone-Remodeling Dynamics and Structure in Hypoparathyroidism
    Rubin, Mishaela R.
    Dempster, David W.
    Sliney, James, Jr.
    Zhou, Hua
    Nickolas, Thomas L.
    Stein, Emily M.
    Dworakowski, Elzbieta
    Dellabadia, Maryann
    Ives, Rebecca
    McMahon, Donald J.
    Zhang, Chiyuan
    Silverberg, Shonni J.
    Shane, Elizabeth
    Cremers, Serge
    Bilezikian, John P.
    JOURNAL OF BONE AND MINERAL RESEARCH, 2011, 26 (11) : 2727 - 2736
  • [26] BONE HISTOMORPHOMETRY AND SERUM CONCENTRATIONS OF INTACT PARATHYROID-HORMONE (PTH(1-84)) IN PATIENTS WITH PRIMARY HYPERPARATHYROIDISM
    VANDOORN, L
    LIPS, P
    NETELENBOS, JC
    HACKENG, WHL
    BONE AND MINERAL, 1993, 23 (03): : 233 - 242
  • [27] Changes in total parathyroid hormone (PTH), PTH-(1-84) and large C-PTH fragments in different stages of chronic kidney disease
    Herberth, J.
    Fahrleitner-Pammer, A.
    Obermayer-Pietsch, B.
    Krisper, P.
    Holzer, H.
    Malluche, H. H.
    Dobnig, H.
    CLINICAL NEPHROLOGY, 2006, 65 (05) : 328 - 334
  • [28] The role of quick Bio-Intact PTH(1-84) assay during parathyroidectomy for secondary hyperparathyroidism
    Ikeda, Yoshifumi
    Kurihara, Hideko
    Morita, Naomi
    Miyabe, Rika
    Takami, Hiroshi
    JOURNAL OF SURGICAL RESEARCH, 2007, 141 (02) : 306 - 310
  • [29] Specific measurement of PTH (1-84) in various forms of renal osteodystrophy (ROD) as assessed by bone histomorphometry
    Lehmann, G
    Stein, G
    Hüller, M
    Schemer, R
    Ramakrishnan, K
    Goodman, WG
    KIDNEY INTERNATIONAL, 2005, 68 (03) : 1206 - 1214
  • [30] Mixed-treatment comparison of anabolic (teriparatide and PTH 1-84) therapies in women with severe osteoporosis
    Migliore, A.
    Broccoli, S.
    Massafra, U.
    Bizzi, E.
    Frediani, B.
    CURRENT MEDICAL RESEARCH AND OPINION, 2012, 28 (03) : 467 - 473